To examine the usefulness of CSR monitoring as a predictor of cardiac disease in OSA patients undergoing CPAP treatment. A Case-Control Study
Not Applicable
- Conditions
- Sleep apnea syndrome
- Registration Number
- JPRN-UMIN000042555
- Lead Sponsor
- Medical corporation MSC Mie Sleep Clinic
- Brief Summary
The median CSB% in stable patients on CPAP treatment was low at 0.32%, with only 24% of patients having CSB% 1% or more. The HF group demonstrated greater CSB variations and longer CL than the non-HF control group. Furthermore, the CL was longer during the exacerbation period of HF even in the same patient.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 775
Inclusion Criteria
Not provided
Exclusion Criteria
1)Major uncontrolled medical or psychiatric conditions 2)The presence of untreated and diagnosable non-OSA sleep disorders (e.g., restless leg syndrome, insomnia, PLMD). 3)Current shift work
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method